Heidelberg Pharma AG
HPHA | XFRA
Overview
Corporate Details
- ISIN(s):
- DE000A11QVV0
- LEI:
- 391200E09XYBYITR1W32
- Country:
- Germany
- Address:
- Gregor-Mendel-Str. 22, 68526 Ladenburg
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Heidelberg Pharma AG based in Ladenburg, Germany, is a biopharmaceutical company listed on the Frankfurt Stock Exchange in the Regulated Market / Prime Standard. The Company was founded in September 1997 by a team of physicians and oncologists from the Technical University of Munich. In 2000, the Company changed to an AG from a GmbH legal structure. In 2011, the subsidiary Heidelberg Pharma Research GmbH was acquired. Heidelberg Pharma was restructured in 2014, which led to the discontinuation of all research and development activities in Munich. The shareholder’s meeting in July 2017 decided to move the registered office of WILEX AG from Munich to Ladenburg and to change the name of the Company to Heidelberg Pharma AG. The subsidiary Heidelberg Pharma GmbH is now named Heidelberg Pharma Research GmbH.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-27 08:07 |
Regulatory News Service
Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-ba…
|
English | 12.1 KB | |
| 2025-05-16 14:31 |
Regulatory News Service
Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting…
|
English | 12.5 KB | |
| 2025-05-14 18:40 |
Regulatory News Service
Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candi…
|
English | 14.1 KB | |
| 2025-04-24 07:16 |
Earnings Release
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial …
|
English | 27.8 KB | |
| 2025-04-24 00:00 |
Regulatory News Service
Q1 statement / Q1 financial report 2024/2025
|
English | 351.9 KB | |
| 2025-04-05 15:06 |
Regulatory News Service
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 15…
|
German | 123.3 KB | |
| 2025-04-03 08:15 |
Regulatory News Service
|
German | 12.7 KB | |
| 2025-03-26 09:23 |
Regulatory News Service
Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Ann…
|
English | 15.9 KB | |
| 2025-03-22 00:00 |
Regulatory News Service
Annual financial report 2023/2024
|
English | 3.7 MB | |
| 2025-03-21 07:07 |
Regulatory News Service
Heidelberg Pharma announces financial figures and reports on successful busines…
|
English | 34.1 KB | |
| 2025-03-21 00:00 |
Regulatory News Service
Annual financial report 2023/2024
|
English | 3.7 MB | |
| 2025-03-14 07:30 |
Regulatory News Service
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
|
English | 13.1 KB | |
| 2025-03-13 00:31 |
Capital/Financing Update
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
|
English | 12.5 KB | |
| 2025-01-24 10:55 |
Report Publication Announcement
|
English | 5.6 KB | |
| 2025-01-23 10:55 |
Report Publication Announcement
|
English | 5.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-31 | Pahl, Prof. Dr. Andreas | Board | Other | None | N/A |
| 2023-12-18 | Pahl, Prof. Dr. Andreas | Board | Buy | None | 10,130.00 EUR |
| 2022-10-13 | 4H invest GmbH | Close relation | Other | None | 993,666.24 EUR |
| 2022-10-13 | Bohlini invest GmbH | Close relation | Other | None | 964,061.56 EUR |
| 2022-10-13 | MH-LT-Investments GmbH | Close relation | Other | None | 506,241.96 EUR |
| 2022-10-13 | Schneiders, Michael | Board | Buy | None | 13,088.40 EUR |
| 2022-10-13 | Schneiders, Michael | Board | Buy | None | 4,895.60 EUR |
| 2022-09-07 | Plate, Achim | Board | Buy | None | 30,869.92 EUR |
| 2022-09-06 | Kudlek, Dr. Birgit | Supervisory board | Other | None | 7,496.16 EUR |
| 2022-03-22 | 4H invest GmbH | Close relation | Other | None | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |